SCHEMBL22472373

SCHEMBL22472373

c1ccc2c(c1)nc1oc3nc(-c4ccc5c(c4)nc4sc6ncncc6n45)ccc3n12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
TSHR P16473 1/20 0.32
MEN1 O00255 2/20 0.31
ALDH1A1 P00352 2/20 0.31
POLB P06746 2/20 0.31
RECQL P46063 2/20 0.31
KMT2A Q03164 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
THRB P10828 1/20 0.31
DUSP3 P51452 2/20 0.30
APAF1 O14727 1/20 0.30
USP2 O75604 1/20 0.30
APEX1 P27695 1/20 0.30
MCL1 Q07820 1/20 0.30
NPC1 O15118 2/20 0.30
TP53 P04637 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23504048 0.78 HSD17B10 (0.55) KDM4EHSD17B10MAPTSMN1; SMN2TSHR
SCHEMBL23504052 0.71 EGFR (0.40) KDM4EHSD17B10MAPTSMN1; SMN2MEN1
SCHEMBL22472575 0.66 RAB9A (0.37) KDM4EHSD17B10MAPTSMN1; SMN2MEN1
SCHEMBL22472366 0.66 KDM4E (0.33) KDM4EHSD17B10MAPTSMN1; SMN2ALDH1A1
SCHEMBL22472375 0.65 KDM4E (0.38) KDM4EHSD17B10MAPTSMN1; SMN2TSHR
SCHEMBL23504075 0.62 NPC1 (0.41) KDM4EHSD17B10MAPTSMN1; SMN2TSHR
SCHEMBL23504077 0.62 HSD17B10 (0.59) KDM4EHSD17B10MAPTSMN1; SMN2TSHR
SCHEMBL16441920 0.62 HSD17B10 (0.52) KDM4EHSD17B10MAPTSMN1; SMN2TSHR
SCHEMBL16441960 0.60 KDM4E (0.44) KDM4EHSD17B10MAPTSMN1; SMN2TSHR
SCHEMBL16441936 0.60 SMN1; SMN2 (0.35) KDM4EHSD17B10MAPTSMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10790455-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10790455-B2 Organic electroluminescent materials and devices ORC3, ALKBH2, ENPP3 KDM4E 1498/4885HSD17B10 3085/4885MAPT 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.